USANA Health Sciences USNA Rise — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's rise — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's rise — cost of sales?
- USANA Health Sciences (USNA) reported rise — cost of sales of $12.7M in Q1 2026.
- What does rise — cost of sales mean?
- Reflects the direct costs associated with the production, manufacturing, and procurement of goods sold within the Rise segment. Monitoring this metric helps assess the direct profitability and production efficiency of this specific product line.